CG
IBRX icon

Cutler Group’s ImmunityBio IBRX Stock Holding History

Cutler Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-86
Closed – – 2843
2023
Q4 		$0 Sell
86
-564
-87% -$1.77K ﹤0.01% 3919
2023
Q3 		$1K Hold
650
– – ﹤0.01% 3526
2023
Q2 		$1K Hold
650
– – ﹤0.01% 3298
2023
Q1 		$1K Sell
650
-4,394
-87% -$13.7K ﹤0.01% 3444
2022
Q4 		$25K Sell
5,044
-3,110
-38% -$17.1K ﹤0.01% 2059
2022
Q3 		$40K Buy
8,154
+3,187
+64% +$14.5K ﹤0.01% 2066
2022
Q2 		$18K Buy
4,967
+2,310
+87% +$9.28K ﹤0.01% 2750
2022
Q1 		$14K Buy
2,657
+2,325
+700% +$14.3K ﹤0.01% 3343
2021
Q4 		$2K Buy
+332
New +$2.49K ﹤0.01% 4743
2021
Q2 		– Sell
-316
Closed -$5.22K – 5976
2021
Q1 		$7K Sell
316
-18,189
-98% -$472K ﹤0.01% 4107
2020
Q4 		$246K Buy
18,505
+1,030
+6% +$9.91K 0.01% 972
2020
Q3 		$121K Buy
17,475
+9,675
+124% +$96.5K 0.01% 1206
2020
Q2 		$95K Buy
7,800
+3,900
+100% +$22K 0.01% 1337
2020
Q1 		$11K Buy
+3,900
New +$19.5K ﹤0.01% 2657
2018
Q3 		– Sell
-3,500
Closed -$10K – 4363
2018
Q2 		$10K Hold
3,500
– – ﹤0.01% 2673
2018
Q1 		$13K Buy
+3,500
New +$15.3K ﹤0.01% 2582
2017
Q4 		– Sell
-2,432
Closed -$13K – 5318
2017
Q3 		$13K Buy
2,432
+2,032
+508% +$12.5K ﹤0.01% 3547
2017
Q2 		$3K Hold
400
– – ﹤0.01% 5244
2017
Q1 		$1K Sell
400
-650
-62% -$3.21K ﹤0.01% 5855
2016
Q4 		$6K Hold
1,050
– – ﹤0.01% 4747
2016
Q3 		$8K Buy
+1,050
New +$7.84K ﹤0.01% 4443
2016
Q2 		– Sell
-400
Closed -$3.1K – 6912
2016
Q1 		$3K Sell
400
-5,500
-93% -$51.8K ﹤0.01% 5269
2015
Q4 		$102K Buy
+5,900
New +$87.5K 0.01% 1752

Other funds holding IBRX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cutler Group's IBRX Position: Q1 2024 in Review

Cutler Group sold out of ImmunityBio (IBRX) in Q1 2024, closing a stake of 86 shares.

Cutler Group first reported a position in IBRX in Q4 2015 and held it in 23 quarters. The position peaked at $246K in Q4 2020. 165 funds tracked by Wall St. Rank hold IBRX as of Q1 2024.

  • Cutler Group reported no remaining ImmunityBio position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 86 ImmunityBio shares in Q1 2024.
  • Cutler Group first reported a position in ImmunityBio in Q4 2015 and held it in 23 quarters.
  • Cutler Group's ImmunityBio position peaked at $246K in Q4 2020.
  • 165 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.